1,12-cyclic-apelin-12 counters vascular smooth muscle cell proliferation and atherosclerosis through inhibiting aerobic glycolysis.
- DOI
- 10.1016/j.taap.2026.117944
- Published
- 2026 Oct
- Container
- Toxicology and applied pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.taap.2026.117944,
title = {1,12-cyclic-apelin-12 counters vascular smooth muscle cell proliferation and atherosclerosis through inhibiting aerobic glycolysis.},
author = {Lu R and Zhou X and Liu H and Fan S and Huang X and Guo F and Huang B and Chen L and Li L},
year = {2026},
journal = {Toxicology and applied pharmacology},
doi = {10.1016/j.taap.2026.117944},
url = {https://doi.org/10.1016/j.taap.2026.117944}
}RIS
TY - JOUR TI - 1,12-cyclic-apelin-12 counters vascular smooth muscle cell proliferation and atherosclerosis through inhibiting aerobic glycolysis. AU - Lu R AU - Zhou X AU - Liu H AU - Fan S AU - Huang X AU - Guo F AU - Huang B AU - Chen L AU - Li L PY - 2026 JO - Toxicology and applied pharmacology DO - 10.1016/j.taap.2026.117944 UR - https://doi.org/10.1016/j.taap.2026.117944 ER -
APA
R, L., X, Z., H, L., S, F., X, H., F, G., B, H., L, C., & L, L. (2026). 1,12-cyclic-apelin-12 counters vascular smooth muscle cell proliferation and atherosclerosis through inhibiting aerobic glycolysis.. Toxicology and applied pharmacology. https://doi.org/10.1016/j.taap.2026.117944
Source records
- pubmed · retrieved 2026-11-10T11:16:16.699Z